Test Strip Market - Growth, Trends, COVID-19 Impact, and Forecast (2022-2027)

The test strip market is segmented by Product (Blood Test Strips and Urine Test Strips), Application (Diabetes, Pregnancy, Urinary Tract Infection, and Others), End-use (Hospitals, Home Care and Diagnostic Laboratories), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above-mentioned segments.

Market Snapshot

Test Strip Market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: Asia-Pacific
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The test strip market is expected to register a CAGR of 4.5% during the forecast period, 2022-2027.

The COVID-19 pandemic has had a significant impact on the studied market. During the initial phase of the pandemic, the demand for test strips was extremely low due to the risk of transmission of the infection. Most of the patients were only permitted to receive treatment for COVID care. However, research and development related to the diagnosis of COVID-19 infection increased tremendously. Researchers at universities, along with prominent market players, developed several test strips for SARS-CoV-2 virus testing. For instance, in December 2021, researchers at UNC-Chapel Hill and the University of California, San Diego, developed a low-cost test strip that provides simple and accurate detection of COVID-19 infection within minutes, and they anticipated that its portability and ease of manufacture could make it globally available, especially in rural or low-income regions that typically lack easy access to expensive PCR (polymerase chain reaction) testing equipment. Thus, such developments have impacted the market's growth significantly over the pandemic phase.

Furthermore, the global test strip market is expected to grow significantly over the projected period, owing to the increased prevalence of diabetes and urinary tract infections (UTIs) around the world. For instance, according to the World Health Organization (WHO) data updated in November 2021, diabetes is expected to be the seventh-leading cause of mortality by 2030, and the prevalence of the disease has been rising more rapidly in low- and middle-income countries. Thus, the increasing burden of diabetes among the population across the world is anticipated to boost the demand for blood glucose test strips, which are widely used for the diagnosis of diabetes, thereby boosting the market. Additionally, increasing the rate of unwanted pregnancy is expected to boost the demand for pregnancy test strips. For instance, the data updated by the United Nations in March 2022 stated that there is a staggering number of unintended pregnancies globally and nearly half of all pregnancies, or approximately 121 million pregnancies each year worldwide, are unintended. Such a high number of unexpected pregnancies is expected to bolster the demand for test trips, thereby boosting the market's growth.

Furthermore, the key players in the market are involved in product innovations and developments. These product launches will have a positive impact on the test strip market's growth. For instance, in March 2022, Mankind Pharma's pregnancy test kit brand introduced a new and enhanced pregnancy detection test kit, "Prega News Advance." The company aims to continue to provide enhanced testing methods for verifying pregnancy. Such launches are propelling the growth of the market.

Thus, all the aforementioned factors are anticipated to drive the market's growth over the forecast period. However, reimbursement and the inaccuracy of test strips will limit the market during the forecast period.

Scope of the Report

As per the scope of the report, test strips are a key component of blood glucose testing and urinalysis. These test strips are used to monitor or control a diabetic patient's blood glucose level. It allows people who are pre-diabetic or diabetic to monitor their blood glucose levels on a regular basis without having to go to a clinic or a diagnostic laboratory. The test strip market is segmented by Product (Blood Test Strips and Urine Test Strips), Application (Diabetes, Pregnancy, Urinary Tract Infection, and Others), End-use (Hospitals, Home Care and Diagnostic Laboratories), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.

By Product
Blood Test Strips
Urine Test Strips
By Application
Diabetes
Preganancy
Urinary Tract Infection
Others
By End Use
Hospitals
Home Care
Diagnostic Laboratories
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Diabetes Segment is Expected to Dominate the Market Over the Forecast Period

With an increase in prevalence and incidence of diabetes globally, the tests for diabetes are also increasing, which is expected to bolster the segment's growth over the forecast period. For diabetic patients, diabetes test strips are a convenient way to check blood sugar levels, often known as glucose levels. This is especially crucial for the diabetic population. The strips read blood sugar levels using glucose meters.

Diabetes is on the rise in both developing and established economies worldwide, contributing to high growth. Another key growth-promoting aspect is the public's increased preference for point-of-care testing. For instance, as per the December 2021 report of the International Diabetes Federation, in 2021, there were about 536 million people (aged 20–79 years) who were living with diabetes around the world, and it is estimated that the total diabetic population will reach 786 million by 2045. Furthermore, technological advancements in the products are anticipated to boost the segment. For instance, in July 2021, Australian scientists developed pain-free blood sugar testing for diabetics, a non-invasive strip that checks glucose levels via saliva.

Additionally, in April 2021, Roche Accu-Chek Instant was launched in the United Kingdom drug tariff with a positive reimbursement price decision of EUR 7.50 for 50 test strips. Such developments by key market players to bring technologically advanced products into the market are expected to boost the segment's growth.

Thus, all the aforementioned factors are expected to boost the segment over the forecast period.

test strips market

North America Dominates the Market and Expected to do Same in the Forecast Period.

Some of the factors that are driving the market growth in the North American region include increasing cases of diabetes and efforts taken by the national government to manage the disease at a larger level, along with rising adoption of test strips and the presence of key market players.

The data updated by the Centers for Disease Control and Prevention (CDC) in January 2022 shows that 37.3 million, or 11.3% of the United States population, have diabetes, among which 28.7 million people, including 28.5 million adults, have been diagnosed with the disease in the country. This population is anticipated to drive the demand for the use of test strips for diabetes, ultimately boosting the market growth.

According to the study titled "Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events," published in January 2022, at some point during their hospital stay, 12 to 16% of adult hospital inpatients in the United States will have an indwelling urinary catheter (IUC). For every day the IUC is left in place, a patient's chance of developing a catheter-associated urinary tract infection increases by 3 to 7% (CAUTI). Thus, overall, the prevalence of complicated UTIs is set to increase during the forecast period, mainly owing to the increasing bacterial resistance in UTI cases and the rise in recurrence rate for UTIs. This is expected to create demand for test strips, driving the market's growth.

Product launches by key market players are expected to further boost the studied market growth. For instance, in March 2021, FemBeat: Lia launched its flushable and biodegradable pregnancy test in the United States, approved by the Food and Drug Administration (FDA).

Thus, all the aforementioned factors are anticipated to boost the market over the forecast period.

Test Strip Market

Competitive Landscape

The competition in the test strip market is rising rapidly. The key players in the test strip market are widening their share by improving demand in developing regions. The key strategies in the competitive landscape are market expansion, acquisitions, and partnerships. The major players include Abbott, Acon Lab, Ascensia, Arkray, B. Braun, Henry Schein, and Lifescan.

Recent Developments

In March 2022, Virtual diabetes clinic 9am.health partnered with Ascensia Diabetes Care to add the Contour Next One blood glucose meter to its patient diabetes toolkit. As part of the collaboration, the clinic’s type 2 diabetes and prediabetes patients can now add Ascensia’s blood glucose meter and 100 to 300 test strips to their personalized treatment plan.

In August 2021, FIND, the global alliance for diagnostics, signed an agreement with i-SENS, Inc. (Seoul, South Korea) and SD BIOSENSOR, Inc. (Suwon-si, South Korea) to increase low- and middle-income countries (LMIC) access to blood glucose test strips by improving affordability.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Diabetes and Urinary Tract Infection Across The Globe

      2. 4.2.2 Rising Preference for Point of Care Testing

      3. 4.2.3 Increasing Technological Advancements in Test Strips

    3. 4.3 Market Restraints

      1. 4.3.1 Dearth of Reimbursement Policies

      2. 4.3.2 Lack of Accuracy in Test Results

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Product

      1. 5.1.1 Blood Test Strips

      2. 5.1.2 Urine Test Strips

    2. 5.2 By Application

      1. 5.2.1 Diabetes

      2. 5.2.2 Preganancy

      3. 5.2.3 Urinary Tract Infection

      4. 5.2.4 Others

    3. 5.3 By End Use

      1. 5.3.1 Hospitals

      2. 5.3.2 Home Care

      3. 5.3.3 Diagnostic Laboratories

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Acon Lab

      3. 6.1.3 Ascensia

      4. 6.1.4 Arkray

      5. 6.1.5 B. Braun

      6. 6.1.6 Lifescan

      7. 6.1.7 Roche Holding AG

      8. 6.1.8 Siemens Healthcare GmbH

      9. 6.1.9 Tiadoc Technology Corporation

      10. 6.1.10 Teco Diagnostics

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Test Strip Market market is studied from 2019 - 2027.

The Global Test Strip Market is growing at a CAGR of 4.5% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

Asia-Pacific holds highest share in 2021.

Abbott, Acon Lab, Ascensia, Arkray, B. Braun are the major companies operating in Global Test Strip Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!